Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Cost-Effectiveness in Medicine An Interactive Introduction Jan J. v. Busschbach, Ph.D. Erasmus MC • Institute for Medical Psychology and Psychotherapy Viersprong Institute for studies on Personality Disorders Presentations can be found at: www.busschbach.nl 1 New cancer therapy Symptoms Drug X Drug Y Survival days Days sick of chemotherapy Days sick of disease TWiST 300 10 100 190 400 150 30 220 2 Time Without Symptoms of disease and subjective Toxic effects of treatment TWiST Developed by Richard Gelber (statistician) In search for a typical “cancer” problem Often prolonged life but also a reductions in quality of life • At the beginning (side effects) • At the end Only count the days without symptoms of disease and subjective toxic effects of the treatment 3 Fit new therapy in fixed budget 50 patients each year (per hospital) Drug x: 50 x euro 1.750 = euro 87.500 Drug y: 50 x euro 2.000 = euro 100.000 Drug budget for x or y = euro 50.000 Number of patient • Drug x: euro 50.000 / 1.750 = 28.5 patients • Drug y: euro 50.000 / 2.000 = 25.0 patients Survival in days • Drug x: 28.5 patients x 300 days = 8.550 days • Drug y: 25.0 patients x 400 days = 10.000 days Survival in TWiST • Drug x: 28.5 patients x 190 TWiST = 5.415 days • Drug y: 25.0 patients x 220 TWiST = 5.500 days 4 TWiST: ignores differences in quality of life TWiST Healthy = 1 Sick (dead) = 0 There is more to life than sick/health Make intermediate values Q-TWiST • Quality of life adjusted adjusted TWiST How to scale quality of life? 5 Value a health state Wheelchair Some problems in walking about Some problems washing or dressing Some problems with performing usual activities Some pain or discomfort No psychosocial problems 6 Time Trade-Off QALY: Quality Adjusted Life Years Wheelchair With a life expectancy: 50 years How many years would you trade-off for a cure? Max. trade-off is 10 years QALY(wheel) = QALY(healthy) Y * V(wheel) = Y * V(healthy) 50 V(wheel) = 40 * 1 V(wheel) = .80 7 EuroQol EQ-5D: of the shelf QALY value MOBILITY SELF-CARE I have no problems with performing my usual activities I have some problems with performing my usual activities I am unable to perform my usual activities PAIN/DISCOMFORT I have no problems with self-care I have some problems washing or dressing myself I am unable to wash or dress myself USUAL ACTIVITIES (e.g. work, study, housework family or leisure activities) I have no problems in walking about I have some problems in walking about I am confined to bed I have no pain or discomfort I have moderate pain or discomfort I have extreme pain or discomfort ANXIETY/DEPRESSION I am not anxious or depressed I am moderately anxious or depressed I am extremely anxious or depressed 8 In health economics: Q-TWiST = QALY Count life years Value (V) quality of life (Q) V(Q) = [0..1] • 1 = Healthy • 0 = Dead One dimension Adjusted life years (Y) for value quality of life QALY = Y * V(Q) • Y: numbers of life years • Q: health state • V(Q): the value of health state Q Also called “utility analysis” 9 Which health care program is the most cost-effective? A new wheelchair for elderly (iBOT) Special post natal care 10 Which health care program is the most cost-effective? A new wheelchair for elderly (iBOT) Increases quality of life = 0.1 10 years benefit Extra costs: $ 3,000 per life year QALY = Y x V(Q) = 10 x 0.1 = 1 QALY Costs are 10 x $3,000 = $30,000 Cost/QALY = 30,000/QALY Special post natal care Quality of life = 0.8 35 year Costs are $250,000 QALY = 35 x 0.8 = 28 QALY Cost/QALY = 8,929/QALY 11 QALY league table Intervention $ / QALY GM-CSF in elderly with leukemia 235,958 EPO in dialysis patients 139,623 Lung transplantation 100,957 End stage renal disease management 53,513 Heart transplantation 46,775 Didronel in osteoporosis 32,047 PTA with Stent 17,889 STIP: Short-term inpatient psychotherapy 7,677 Breast cancer screening 5,147 Viagra 5,097 Treatment of congenital anorectal malformations 2,778 12 Egalitarian Concerns: Burden of disease 1.0 0.0 A B C 13 Implications shifting threshold QALY are weighted Weighted QALYs are maximized Health is no longer the only thing maximized Health status population will drop Differences in health will drop Egalitarian consideration are incorporated Burden of disease becomes a criteria Equity 14 CE-ratio by equity 15 Conclusion Cost effectiveness in medicine can be measured Burden of disease is also a criterion 16